EFFICACY AND DISCONTINUATION RATE OF IBRUTINIB IN TREATMENT NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH TP53 ABNORMALITIES. A REAL‐LIFE CAMPUS CLL STUDY.

Details

Language :

English

ISSN :

02780232

Volume :

39

Database :

Complementary Index

Journal :

Hematological Oncology

Publication Type :

Academic Journal

Accession number :

150947542

Full Text :

https://doi.org/10.1002/hon.46_2880